Skip to main content
Veterinary Medicines

ΑLBENDAZOLE 300/ANAFASIS, δισκία 300 mg/tab για πρόβατα

Authorised
This information is not available for this product.

Product identification

Medicine name:
ΑLBENDAZOLE 300/ANAFASIS, δισκία 300 mg/tab για πρόβατα
Active substance:
This information is not available for this product.
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        10
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC11
Authorisation status:
  • Valid
Authorised in:
This information is not available for this product.
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Uplab Pharmaceutical Company Ltd.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 95613/20-10-2021/K-0160301
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 19/09/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 19/09/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."